MIRUM PHARMACEUTICALS

mirum-pharmaceuticals-logo

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

MIRUM PHARMACEUTICALS

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2018-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.mirumpharma.com

Total Employee:
11+

Status:
Active

Contact:
650-667-4085

Email Addresses:
[email protected]

Total Funding:
222 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins


Similar Organizations


Current Advisors List

ed-mathers_image

Ed Mathers Board Member @ Mirum Pharmaceuticals
Board_member

mike-grey_image

Mike Grey Board Member @ Mirum Pharmaceuticals
Board_member

tiba-aynechi_image

Tiba Aynechi Board Member @ Mirum Pharmaceuticals
Board_member
2018-10-01

laurent-fischer_image

Laurent Fischer Board Member @ Mirum Pharmaceuticals
Board_member
2019-06-01

chris-peetz_image

Chris Peetz Board Member @ Mirum Pharmaceuticals
Board_member

patrick-heron_image

Patrick Heron Board Member @ Mirum Pharmaceuticals
Board_member
2018-11-01

jonathan-leff_image

Jonathan Leff Board Member @ Mirum Pharmaceuticals
Board_member

niall-odonnell_image

Niall O'Donnell Board Member @ Mirum Pharmaceuticals
Board_member

Current Employees Featured

ian-clements_image

Ian Clements
Ian Clements Chief Financial Officer @ Mirum Pharmaceuticals
Chief Financial Officer
2019-03-01

alejandro-dorenbaum_image

Alejandro Dorenbaum
Alejandro Dorenbaum Co-founder @ Mirum Pharmaceuticals
Co-founder

niall-odonnell_image

Niall O&s;Donnell
Niall O'Donnell Co-founder @ Mirum Pharmaceuticals
Co-founder

paul-ross_image

Paul Ross
Paul Ross Chief Compliance Officer @ Mirum Pharmaceuticals
Chief Compliance Officer

peter-radovich_image

Peter Radovich
Peter Radovich COO @ Mirum Pharmaceuticals
COO

thomas-jaecklin_image

Thomas Jaecklin
Thomas Jaecklin Senior Vice President @ Mirum Pharmaceuticals
Senior Vice President

elaine-chien_image

Elaine Chien
Elaine Chien Executive Medical Director, Clinical Development @ Mirum Pharmaceuticals
Executive Medical Director, Clinical Development
2020-02-01

not_available_image

Christopher Peetz
Christopher Peetz Chief Executive Officer @ Mirum Pharmaceuticals
Chief Executive Officer
2019-03-01

chris-peetz_image

Chris Peetz
Chris Peetz President & Chief Executive Officer @ Mirum Pharmaceuticals
President & Chief Executive Officer
2019-03-01

ian-clements_image

Ian Clements
Ian Clements Chief Financial Officer @ Mirum Pharmaceuticals
Chief Financial Officer
2019-03-01

Founder


alejandro-dorenbaum_image

Alejandro Dorenbaum

niall-odonnell_image

Niall O'Donnell

not_available_image

Susan Dubé

Stock Details


Company's stock symbol is NASDAQ:MIRM

Investors List

oberland-capital_image

Oberland Capital

Oberland Capital investment in Post-IPO Equity - Mirum Pharmaceuticals

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Series A - Mirum Pharmaceuticals

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series A - Mirum Pharmaceuticals

rivervest_image

RiverVest

RiverVest investment in Series A - Mirum Pharmaceuticals

pappas-capital_image

Pappas Capital

Pappas Capital investment in Series A - Mirum Pharmaceuticals

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Mirum Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series A - Mirum Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series A - Mirum Pharmaceuticals

chiesi-ventures_image

Chiesi Ventures

Chiesi Ventures investment in Series A - Mirum Pharmaceuticals

Key Employee Changes

Date New article
2020-04-28 Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer

Official Site Inspections

http://www.mirumpharma.com Semrush global rank: 4.47 M Semrush visits lastest month: 2.44 K

  • Host name: 165.145.227.35.bc.googleusercontent.com
  • IP address: 35.227.145.165
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Mirum Pharmaceuticals" on Search Engine